Assertio appoints Sravan Emany to Board of Directors, effective Nov 14.

Assertio Holdings, Inc.

Board expanded from 6 to 7 members; Emany fills new vacancy created by increase.
Emany is CFO of Ironwood Pharmaceuticals, with prior roles at Integra LifeSciences and Bank of America.
Appointed to Audit Committee; receives standard non-employee director compensation and indemnification.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sravan Emany

Director

ASRT · Assertio Holdings, Inc.

Effective: 2023-11-14
Filed: November 14, 2023, 6:59 PM ET

appointed Sravan Emany to the Board, to fill the vacancy created by the increase in the number of directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Sravan Emany was appointed as Director at Assertio Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Sravan Emany to the Board, to fill the vacancy created by the increase in the number of directors.

View on SEC.gov

Assertio Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-117706

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.